Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs. LPI (LP Information)' newest research report, the ﾓSpine Biologics Industry Forecastﾔ looks at past sales and reviews total world Spine Biologics sales in 2022, providing a comprehensive analysis by region and market sector of projected Spine Biologics sales for 2023 through 2029. With Spine Biologics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Spine Biologics industry. This Insight Report provides a comprehensive analysis of the global Spine Biologics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Spine Biologics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Spine Biologics market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Spine Biologics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Spine Biologics. The global Spine Biologics market size is projected to grow from US$ 2311.6 million in 2022 to US$ 2925.8 million in 2029; it is expected to grow at a CAGR of 2925.8 from 2023 to 2029. Global Spine Biologics key players include Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive, Zimmer Biomet, etc. Global top five manufacturers hold a share over 75%. North America is the largest market, with a share over 60%, followed by Europe and Asia (Ex. China), both have a share about 30%. In terms of product, Bone Graft is the largest segment, with a share over 55%. And in terms of application, the largest application is Posterior Lumbar Interbody Fusion, followed by Anterior Cervical Discectomy and Fusion, etc. This report presents a comprehensive overview, market shares, and growth opportunities of Spine Biologics market by product type, application, key manufacturers and key regions and countries. Market Segmentation: Segmentation by type Bone Graft Bone Graft Substitute Platelet Rich Plasma (PRP) BMAC (Bone Marrow Aspirate Concentrate) Segmentation by application Anterior Cervical Discectomy and Fusion Posterior Lumbar Interbody Fusion Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Medtronic Depuy Synthes Stryker Corporation Nuvasive Zimmer Biomet Orthofix International Globus Medical alphatec spine K2M Exactech Wright Medical Technology X-Spine Nutech Arthrex Key Questions Addressed in this Report What is the 10-year outlook for the global Spine Biologics market? What factors are driving Spine Biologics market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Spine Biologics market opportunities vary by end market size? How does Spine Biologics break out type, application? What are the influences of COVID-19 and Russia-Ukraine war?
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Spine Biologics Annual Sales 2018-2029 2.1.2 World
